Professor Bertil E. Lindmark M.D.

Professor Bertil E. Lindmark MD, PhD, currently serves as Chief Medical Officer at Vicore Pharma AB and Chairman of the Board at AQILION AB, while also holding board positions at ALK and Cellevate AB. With extensive experience in medical and scientific leadership across various organizations, Lindmark has previously held roles as Chief Medical Officer at Galecto, Inc., and eTheRNA immunotherapies, along with significant positions at ASLAN Pharmaceuticals and Almirall. Lindmark's academic contributions include a professorship in Innovation and Entrepreneurship at the Faculty of Medicine, Gothenburg University. Lindmark's educational background includes a Doctor of Medicine and a Doctor of Philosophy from Lund University, as well as completion of the Advanced Management Program at INSEAD.